Angel investor · United States
Recorded investments.
A clearer sense of fit.
Find where your company fits, how rounds are assembled, and what happened after the first investment.
of dated first investments
were at Angel, Pre-Seed or Seed
One dot = one company at first recorded investment.
Written insights from the recorded portfolio, with the evidence linked below.
Anne Wojcicki has dated investments in 32 companies. 11 first entries were at Angel, Pre-Seed or Seed (34.4%). An early-stage founder can use the sector and stage filters to find comparable companies before approaching the investor.
Explore the evidence ↗3 first company relationships appear in the latest 24 months, compared with 12 in the preceding window. The latest recorded investment is 2026-01-20. This describes observed activity through 2026-05-22; it does not establish current availability.
Explore the evidence ↗6 of 29 companies with a full 24-month observation window raised another equity round. This investor backed 0 of those companies again within that window. The difference is a reason to research the wider syndicate, rather than assume the same investor will fund the next round.
Explore the evidence ↗HealthTech is the largest displayed sector by company count, appearing in 17 portfolio companies; sector tags overlap. 0 first entries carry a recorded lead flag and the median first-round syndicate includes 8 other named backers. Shared rounds are evidence of co-investment, not evidence of an introduction route.
Explore the evidence ↗Start with observed behavior.
Every rate has a defined denominator.
25th–75th percentile across 31 disclosed first rounds. Total round size; the investor’s own cheque is undisclosed.
Size your round ↗22 May 2024–22 May 2026, versus 12 in the preceding 24 months.
See the rhythm ↗6 of 29 companies with a full observation window. The next round can include any investor.
Follow the path ↗0 of the same 29 companies. Build a financing plan around the wider investor market.
Explore co-investors ↗Choose your sector and stage to find
companies he first backed in that space.
A match means a recorded investment in this category. It does not establish current interest or availability.
All sectors · All entry stages. Round amounts are total financing, in USD.
Developer of human-centered artificial intelligence models and connective tissue platforms
$480M total first roundProvider of patient centered healthcare platform
$14M total first roundAI-powered digital companion for managing diabetes
Undisclosed total first round| Sector | Seed | Series A | Series B | All stages |
|---|---|---|---|---|
| HealthTech | 17 | |||
| Healthcare IT | 10 | |||
| Healthcare Booking Platforms | 6 | |||
| Life Sciences | 6 | |||
| Clinical Data Repository | 4 | |||
| Women Health | 3 | |||
| At Home Diagnostics | 2 |
Use stage-specific financing ranges
to frame the size of your syndicate.
Logarithmic scale. A dot marks the median; the band spans the 25th–75th percentiles. These are entire rounds, not individual cheques.
A subsequent round and repeat backing
answer different fundraising questions.
Includes first investments on or before 22 May 2024. 3 newer companies and 0 undated histories are excluded. Follow-up stops at the dataset’s latest round on 22 May 2026. These observations do not measure returns or predict a company’s outcome.
| First stage | Eligible companies | Next round ≤24 mo | Same investor again ≤24 mo |
|---|---|---|---|
| Seed | 9 | 0 / 9 | 0 / 9 |
| Series A | 11 | 3 / 11 | 0 / 11 |
| Series B | 5 | 1 / 5 | 0 / 5 |
| Series C | 3 | 2 / 3 | 0 / 3 |
| Series E+ | 1 | 0 / 1 | 0 / 1 |
Separate first investments from later
rounds in companies already backed.
*2026 is partial, through 22 May. Bar height counts first investments + repeat rounds; earlier years are complete calendar periods in this dataset.
Frequent shared rounds suggest a place
to investigate sector and stage alignment.
4 shared rounds · 4 companies
Latest shared round Jan 20233 shared rounds · 3 companies
Latest shared round Jan 20233 shared rounds · 3 companies
Latest shared round Jun 20213 shared rounds · 3 companies
Latest shared round Jan 20223 shared rounds · 3 companies
Latest shared round Jul 2024Shared rounds establish recorded co-investment. They do not establish a personal connection, introduction route, or current willingness to invest.
First investment comes first.
Amounts refer to that entry round.
| Company | First backed | Entry stage | Total entry round | Same investor again? |
|---|---|---|---|---|
humans& ↗Redwood City | Jan 2026 | Seed | $480M | No later round recorded |
Solace Health ↗Redwood City | Aug 2024 | Series A | $14M | No later round recorded |
Endo Health ↗San Francisco | Jul 2024 | Seed | Undisclosed | No later round recorded |
Brightside Health ↗San Francisco | Mar 2024 | Series C | $33M | No later round recorded |
Ezra ↗New York City | Feb 2024 | Series B | $21M | No later round recorded |
Orchid ↗Armadale | Dec 2023 | Series A | $12M | No later round recorded |
Eureka Health ↗Sacramento | Jul 2023 | Seed | $7.0M | No later round recorded |
Helium Health ↗Lekki | Jun 2023 | Series B | $30M | No later round recorded |
Nest Genomics ↗Manhattan | Jan 2023 | Seed | $8.5M | No later round recorded |
Wisdo ↗Ramat Hasharon | Jan 2023 | Series A | $11M | No later round recorded |
Prenuvo ↗San Francisco | Oct 2022 | Series A | $70M | No later round recorded |
Halo ↗Chicago | Sep 2022 | Seed | $2.6M | No later round recorded |
Tract ↗San Francisco | Sep 2022 | Seed | $7.0M | No later round recorded |
Bristle ↗San Francisco | Jul 2022 | Seed | $3.0M | No later round recorded |
Tesorio ↗San Francisco | Jun 2022 | Series B | $17M | No later round recorded |
Volta Labs ↗Cambridge | Mar 2022 | Series A | $20M | No later round recorded |
Gameto ↗United States | Jan 2022 | Series A | $20M | Yes · May 2024 |
Akido Labs ↗Los Angeles | Dec 2021 | Series A | $11M | No later round recorded |
Biobot Analytics ↗Cambridge | Oct 2021 | Series A | $20M | No later round recorded |
Intro ↗Los Angeles | Oct 2021 | Seed | $10M | No later round recorded |
Apeel ↗Goleta | Aug 2021 | Series E+ | $250M | No later round recorded |
Getlabs ↗Santa Monica | Aug 2021 | Series A | $20M | No later round recorded |
TMRW ↗New York City | Jun 2021 | Series C | $80M | No later round recorded |
Kindra ↗Santa Monica | Jun 2021 | Seed | $4.5M | No later round recorded |
adyn ↗Seattle | Apr 2021 | Seed | $2.5M | No later round recorded |
SteadyMD ↗St. Louis | Mar 2021 | Series B | $28M | No later round recorded |
Seqster ↗San Diego | Mar 2021 | Series A | $12M | No later round recorded |
ixLayer ↗San Francisco | Feb 2021 | Series A | $75M | No later round recorded |
theator ↗Tel Aviv | Feb 2021 | Series A | $16M | No later round recorded |
Base ↗New York City | Feb 2021 | Seed | $3.4M | No later round recorded |
Sidecar Health ↗El Segundo | Jul 2020 | Series B | $20M | No later round recorded |
Maven ↗New York City | Feb 2020 | Series C | $45M | No later round recorded |
No companies match these filters. Try a broader sector or stage.
Kept in the 32-company portfolio; excluded from entry-timing calculations.
Search , United States investor companies in Radar. Filter the company directory to explore the businesses behind your market and investor research.
Explore companies in Radar ↗We build customized research dashboards for companies. Tell us which competitors, markets and questions matter to your team, and discuss a dashboard designed around your needs.
Discuss a custom dashboard ↗A customized service from Fliar. Contact us to discuss your requirements.Use Fliar Prism to research a company, market or topic, with reports and insights drawn from its research dataset.
Explore Fliar Prism ↗Start with the company or question you want to understand.